All schemes

Biotechnology Industry Research Assistance Council (BIRAC)

BIRAC Biotechnology Industry Partnership Programme (BIPP)

BIRAC BIPP advanced biotechnology cost-sharing support

Grants & awards Advanced research grant Recurring intake
Official portal

What it is

Support high-risk, novel and commercially or nationally relevant biotechnology development that moves toward validation and commercialisation, with IP ownership retained by Indian industry where applicable.

What you get

  • BIRAC BIPP advanced biotechnology cost-sharing support

Who it is for

  • the applicant is an Indian company or LLP or an eligible consortium with an academic/research collaborator
  • at least 51% of company shares are held by Indian citizens, or the applicable LLP partner condition is met
  • the applicant has adequate in-house capability or is incubated at a recognised facility
  • the proposal is high-risk and transformational rather than incremental development
  • the project ends at TRL 7 or above for the advanced technology route and fits a BIPP category
  • the applicant is not in a disqualifying default, duplicate-funding or prior-project irregularity state
CompanyLlpIndustry academic consortiumResearch institution collaboratorAdvanced researchValidationClinical trialField trialCommercialisationBiotechnologyPharmaceuticalsVaccinesBiosimilarsStem cellsMedical devicesDiagnosticsAgriculture biotechnologyBioenergyIndustrial biotechnologyBioinformaticsIndia

How to apply

  1. 1
    Select the BIPP category and call

    Review the current BIPP page, call notice and seven broad themes; identify whether the proposal is Category I/II, III-A, III-B or IV.

    Official step
  2. 2
    Prepare technical and compliance dossier

    Document novelty, TRL, preliminary data, collaborator, IP, regulatory, budget, milestones, cost sharing and site/facility evidence.

    Official step
  3. 3
    Submit during the active call

    Use the BIRAC proposal route and submit the category-specific proforma and supporting documents before the call closes.

    Official step

Keep ready

Transformational biotech project with TRL, cost-sharing, IP and regulatory evidence